Biotechnology July 29, 2026 Latigo Reports Mid-Stage Success for Would-Be Rival to Vertex’s Pain Drug Journavx
Biotechnology June 29, 2026 ‘There’s room for multiple winners’: Talawar Heads to Nasdaq via SPAC Deal to Bankroll Eczema Asset